Contact UsSiteMap
Home Fashion magazine Sports Equipment Hotel catering Game live Business Finance More

Sports Equipment

MediBeacon® Transdermal GFR System receives device approval in China; Peer-reviewed articles on MediBeacon technology published

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function.

02-26

BUYING SQUARE Opens Experiential Brand Showroom 'VIBE TWLV' in Brooklyn

NEW YORK,Feb. 25,2025-- BUYING SQUARE,operator of the next-generation digital wholesale platform Catalog Shop,unveiled its experiential brand showroom,VIBE TWLV,in Brooklyn,New York. The 4,270-square-

02-26

Risen Achieves 30.99% Efficiency with HJT-Perovskite Tandem Solar Cells!

NINGBO,China,Feb. 26,2025-- Breaking new ground in solar innovation! Risen\'sHJT (Heterojunction Technology),when combined with aperovskitecell in a tandem structure,has achieved an impressive30.99% e

02-26

Little Artists Students from Singapore Shine at Art Capital 2025 at Grand Palais, Paris

PARIS,Feb. 25,2025-- Little Artists Art Studio,is proud to share the historic debut of their young and rising talents at the prestigious Art Capital Paris: Le Salon des Artistes Français at the

02-26

Guo Guangchang: Fosun Emphasizes Strategic Advancement and Exits, Focuses on Core Businesses, and Leverages Operational Capabilities to Participate in Global Markets

HONG KONG,Feb. 25,2025-- On 21 February,Guo Guangchang,Chairman of Fosun International spoke at the 25th Annual Conference of Yabuli China Entrepreneurs Forum 2025,stating that private enterprises are

02-26

BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED)

SHANGHAI,Feb. 23,2025-- BioCityBiopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist,SC0062,met the 12-week primary endpoint of a reduction in proteinuria in the

02-26

CStone Announces Publication of GEMSTONE-303 Study Results for Sugemalimab (Cejemly®) in JAMA

Sugemalimab is the world\'s first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. The GEMSTONE-303 study results support sugem

02-26

Pudu Robotics Enhances Cleaning Efficiency at Ryugujo Spa Hotel Mikazuki Ryugutei with the Introduction of PUDU SH1

SHENZHEN,China,Feb. 25,2025--Pudu Robotics,a global leader in service robotics,is revolutionizing cleanliness standards at Ryugujo Spa Hotel Mikazuki Ryugutei in Japan,a renowned Japanese hot spring

02-26

MicuRx Pharmaceutical: Contezolid Global Phase III Clinical Trial Safety and Efficacy Evaluation Endorsed by Data Monitoring Committee, Promising Prospects for Diabetic Foot Infection Treatment

Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial,recommending continued progression as planned

02-26

Emirates to hold its first ever pilot recruitment roadshow in Macao

DUBAI,UAE,Feb. 25,2025-- Emirates,as the international airline based in Dubai,has announced its first series of pilot recruitment roadshows in Macao Special Administrative Region,China to meet the str

02-26

Home Previous 7 8 9 10 11 12 13 Next Tail

10 Items Per Page (Page 10 / 77) Total 767 Items

Disclaimer

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.
©copyright 2009-2020 The Poker Daily    Contact Us SiteMap